Cationic Palladium(II) Alkyl Complexes
Organometallics, Vol. 26, No. 27, 2007 6733
(m-Ph), 121.5, 121.4, 56.2 (NMe), 50.2 (NMe), 38.2, 34.3, 33.9,
33.6, 31.7, 29.3, 27.5, 22.8, 14.2, 2.2 (PdMe).
7a had formed quantitatively. 1H NMR (CD2Cl2): δ 7.03 (br s,
2H, mim H4/H5), 6.86 (s, 1H, mim H4/H5), 6.83 (s, 1H, mim H4/
H5), 4.14 (s, 2H, CH2), 3.74 (s, 3H, mim NMe), 3.72 (s, 3H, mim
NMe), 2.66 (s, 3H, COMe). 13C{1H} NMR (CD2Cl2): δ 217.4
(C(O)Me), 173.7 (PdCO), 141.8, 140.4, 128.5, 127.5, 123.5, 123.2,
40.8 (COMe), 34.8 (mim NMe), 34.2, (mim NMe), 23.1 (CH2).
The 13C NMR assignments were confirmed by 13CO experiments.
IR (CD2Cl2, cm-1): 2121 (VCO), 1734 (Vacyl).
Generation of [{1,1′-Di(triphenylmethyl)-4,4′-biimidazole}-
PdMe(NMe2Ph)][B(C6F5)4] (5c). This compound was generated
quantitatively from 2c and [HNMe2Ph][B(C6F5)4] using the pro-
cedure for 5b. 1H NMR (CD2Cl2, -60 °C): δ 7.61 (s, 1H, imidazole
H5/H5′), 7.52 (d, J ) 8, o-Ph), 7.33 (m, 18H, trityl H3 and H4),
7.08 (d, J ) 8, 6H, trityl H2), 6.90 (d, J ) 8, 6H, trityl H2), 6.80
(s, 1H, imidazole H2), 6.73 (t, J ) 8, 1H, p-Ph), 5.30 (s, 1H,
imidazole H2′), 3.01 (s, 3H, NMe), 2.98 (s, 3H, NMe), 0.82 (s,
3H, PdMe). 13C NMR (CD2Cl2, -60 °C): 153.4, 140.4, 140.2, 136.8
(imidazole C4/C4′), 136.6 (imidazole C4/C4′), 135.0 (imidazole
C2/C2′), 132.4 (imidazole C2/C2′), 129.3, 129.0, 128.5, 128.4,
128.2, 128.1, 126.5, 116.4 (imidazole C5/C5′), 116.1 (imidazole
C5/C5′), 76.8 (C(C6H5)3), 75.8 (C(C6H5)3), 52.1 (NMe2Ph), 0.04
(PdMe).
Generation of [{1,1′-Di(triphenylmethyl)-4,4′-biimidazole}-
Pd{C(dO)Me}(CO)][B(C6F5)4] (7c). This compound was generated
quantitatively from 2c, [HNMe2Ph][B(C6F5)4], and CO (5 atm) using
1
the procedure for 7a. H NMR (CD2Cl2, -40 °C): δ 7.57 (s, 1H,
imidazole H), 7.38 (m, 19 H, trityl and imidazole H), 7.25 (d, J ) 8,
12 H, trityl H2), 7.11 (s, 1H, imidazole H), 7.09 (s, 1H, imidazole H),
2.61 (s, 3H, COMe). 13C{1H} NMR (CD2Cl2, -40 °C): δ 213.0
(C(O)Me), 173.5 (PdCO), 140.5, 140.1, 139.2 (imidazole C4/C4′),
138.5 (imidazole C4/C4′), 134.3 (imidazole C2/C2′), 132.4 (imidazole
C2/C2′), 129.4 (2 C), 128.8, 128.7, 128.5, 128.4, 77.5, 77.1, 41.8
(COMe). IR (CD2Cl2, cm-1): 2123 (VCO). The Vacyl stretch was not
observed due to overlap with a solvent stretch.
Generation of [{H2C(pz)2}PdMe(NMe2Ph)][B(C6F5)4] (5e).
This compound was generated quantitatively from 2e and
[HNMe2Ph][B(C6F5)4] using the procedure for 5b. 1H NMR
(CD2Cl2, -60 °C): δ 7.79 (d, J ) 8, 2H, o-Ph), 7.71 (d, J ) 3, 1H,
5-pz), 7.59 (d, J ) 2, 1H, 5′-pz), 7.56 (d, J ) 2, 1H, 3-pz), 7.47 (t,
J ) 8, 2H, m-Ph), 7.34 (t, J ) 8, 1H, p-Ph), 6.87 (d, J ) 14, 1H,
CHax), 6.41 (t, J ) 2, 1H, 4-pz), 6.15 (d, J ) 14, 1H, CHeq), 6.05
(t, J ) 2, 1H, 4′-pz), 5.27 (d, J ) 2, 1H, 3′-pz), 3.19 (s, 3H, NMe),
2.83 (s, 3H, NMe), 1.09 (s, 3H, PdMe). 13C NMR (CD2Cl2, -60
°C): δ 152.0, 143.5, 141.9, 132.4, 132.0, 129.3, 127.3, 121.7, 108.2,
107.5, 63.3 (CH2), 55.5 (NMe), 49.6 (NMe), 4.9 (PdMe).
Generation of [{H2C(5-Me-py)2}Pd{C(dO)Me}(CO)][B-
(C6F5)4] (7d). This compound was generated quantitatively from
2d, [HNMe2Ph][B(C6F5)4], and CO (5 atm) using the procedure
1
for 7a. H NMR (CD2Cl2, -40 °C): δ 8.23 (s, 1H, py H6/H6′),
8.12 (s, 1H, py H6/H6′), 7.74 (d, J ) 8, 1H, py H4/H4′), 7.68 (d,
J ) 8, 1H, py H4/H4′), 7.47 (d, J ) 8, 1H, py H3/H3′), 7.44 (d, J
) 8, 1H, py H3/H3′), 4.71 (d, J ) 15, 1H, CH2 Hax), 4.30 (d, J )
15, 1H, CH2 Heq), 2.64 (s, 3H, COMe) 2.33 (s, 3H, py 5-Me), 2.30
(s, 3H, py 5-Me). 13C{1H} NMR (CD2Cl2, -40 °C): δ 218.0
(C(O)Me), 173.0 (PdCO), 151.9 (py C2/C2′), 151.1 (py C6/C6′),
150.8 (py C2/C2′), 148.7 (py C6/C6′), 142.3 (py C4/C4′), 141.5
(py C4/C4′), 135.3 (py C5/C5′), 135.1 (py C5/C5′), 125.7 (py C3/
C3′), 125.4 (py C3/C3′), 45.7 (COMe), 40.9 (CH2) 18.1 (py 5-Me),
17.8 (py 5-Me). IR (CD2Cl2, cm-1): 2128 (VCO), 1741 (Vacyl).
Generation of [(p-Tolyldiimine)PdMe(NMe2Ph)][B(C6F5)4]
(p-tolyldiimine ) (4-Me-C6H4)NdCMeCMedN(4-Me-C6H4))
(5g). This compound was generated quantitatively from 2g and
[HNMe2Ph][B(C6F5)4] using the procedure for 5b. 1H NMR
(CD2Cl2, -60 °C): δ 7.27 (d, J ) 8, 2H, Ar), 7.21 (m, 2H,
NMe2Ph), 7.16 (m, 3H, NMe2Ph), 6.97 (d, J ) 8, 2H, Ar), 6.79
(d, J ) 8, 2H, Ar), 6.24 (d, J ) 8, 2H, Ar), 2.61 (s, 6H, NMe2Ph),
2.35 (s, 3H, 4-Me-C6H4), 2.29 (s, 3H, 4-Me-C6H4), 2.05 (s, 3H,
NdCMe), 1.93 (s, 3H, NdCMe), 0.43 (s, 3H, PdMe). 13C NMR
(CD2Cl2, -60 °C): δ 178.5 (NdCMe), 173.5 (NdCMe), 151.9,
143.9, 143.8, 137.3, 136.1, 130.2, 129.8, 129.0, 126.5, 120.7, 120.6,
118.5, 52.2 (NMe2), 21.7, 20.7, 20.6, 20.1, 13.2 (PdMe).
Generation of [{H2C(pz)2}Pd{13C(dO)Me}(13CO)][B(C6F5)4]
(7e). This compound was generated quantitatively from 2e,
[HNMe2Ph][B(C6F5)4], and 13CO (1 atm) using the procedure for
7a. 1H NMR (CD2Cl2, -20 °C): δ 7.81 (br s, 2H, pz H5/H5′),
7.64 (br s, 2H, pz H3/H3′), 6.39 (br s, 2H, pz H4/H4′), 6.39 (br s,
2H, CH2), 2.76 (d, JC-H ) 6, 3H, COMe). 13C{1H} NMR (CD2Cl2,
-10 °C): δ 209.8 (C(O)Me), 175.0 (br s, PdCO),144.5 (br s, pz
C5/C5′), 129.2 (pz C3/C3′), 109.1 (pz C4/C4′), 63.7 (CH2), 40.0
(d, JC-C ) 32, COMe). IR (CD2Cl2, cm-1): 2133 (VCO), 1756 (Vacyl).
Generation of [{H2C(3,5-Me2-pz)2}PdMe(OEt2)][SbF6] (6f′). A
valved NMR tube was charged with 3f (0.0072 g, 0.020 mmol)
and Ag[SbF6] (0.0069 g, 0.020 mmol), and Et2O (1.0 mL) was
added by vacuum transfer at -78 °C. The tube was sealed, briefly
warmed to 23 °C, and vigorously shaken for 10 min. A slurry of a
fine white solid in a colorless supernatant was obtained. The
volatiles were removed under vacuum. The tube was cooled to -78
°C, and CD2Cl2 (0.7 mL) was added by vacuum transfer. The tube
was kept at -78 °C and transferred to a precooled (-60 °C) NMR
Generation of [{H2C(3,5-Me2-pz)2}Pd{C(dO)Me}(CO)]-
[B(C6F5)4] (7f). A valved NMR tube containing a CD2Cl2 (0.7 mL)
solution of 3f (0.0056 g, 0.016 mmol) and [Li(Et2O)2.8][B(C6F5)4]
(0.014 g, 0.016 mmol) was cooled to -196 °C and exposed to CO
(5 atm). The tube was sealed and warmed to -78 °C. The tube
was briefly warmed to 23 °C and vigorously shaken. A slurry of a
fine white solid in a colorless supernatant was obtained. The tube
was kept at -78 °C and transferred to a precooled (-60 °C) NMR
1
probe, and NMR spectra were recorded. The H NMR spectrum
1
established that 6f′ had formed quantitatively. H NMR (CD2Cl2,
-60 °C): δ 6.78 (d, J ) 15, 1H, CH2 Hax), 6.21 (d, J ) 15, 1H,
CH2 Heq), 6.07 (s, 1H, pz H4/H4′), 5.86 (s, 1H, pz H4/H4′), 3.70
(m, 4H, coord. Et2O CH2), 2.37 (s, 3H, pz Me), 2.33 (s, 3H. pz
Me), 2.27 (s, 3H, pz Me), 2.14 (s, 3H, pz Me), 1.63 (t, J ) 7, 6H,
coord. Et2O CH3), 0.79 (s, 3H, PdMe). 13C{1H} NMR (CD2Cl2,
-60 °C): δ 152.7 (3/3′-pz), 150.6 (3/3′-pz), 142.3 (5/5′-pz), 140.7
(5/5′-pz), 108.1 (4/4′-pz), 106.9 (4/4′-pz), 71.8 (Et2O CH2), 57.2
(CH2), 15.6 (Et2O CH3), 14.5, 12.9, 11.2, 10.6, -4.5 (PdMe).
Resonances for free Et2O were also present.
1
probe, and NMR spectra were recorded. The H NMR spectrum
1
established that 7f had formed quantitatively. H NMR (CD2Cl2,
-60 °C): δ 6.43 (d, J ) 15, 1H, CH2 Hax), 6.05 (d, J ) 15, 1H,
CH2 Heq), 6.03 (s, 1H, pz H4/H4′), 5.97 (s, 1H, pz H4/H4′), 2.62
(s, 3H, (COMe)), 2.36 (s, 3H, pz Me), 2.34 (s, 3H. pz Me), 2.22
(s, 3H, pz Me), 2.11 (s, 3H, pz Me). 1H NMR (CD2Cl2, 25 °C): δ
6.45 (br s, 1H, Hax), 6.22 (br s, 1H, Heq), 6.04 (s, 2H, pz H), 2.65
(s, 3H, COMe), 2.39 (s, 6H, pz Me), 2.22 (s, 6H, pz Me). 13C{1H}
NMR (CD2Cl2, -60 °C): δ 211.3 (C(O)Me), 171.7 (PdCO), 153.1
(3/3′-pz), 152.2 (3/3′-pz), 142.8 (5/5′-pz), 141.1 (5/5′-pz), 108.7
(4/4′-pz), 107.6 (4/4′-pz), 56.9 (CH2), 40.4 (COMe), 13.9, 13.6,
11.0, 10.6. IR (CD2Cl2, cm-1): 2132 (VCO). The Vacyl band was not
observed due to overlap with a solvent band.
Generation of [{H2C(mim)2}Pd{C(dO)Me}(CO)][B(C6F5)4] (7a).
A solution of 5a in CD2Cl2 (0.7 mL) was generated in a valved
NMR tube from 2a (0.0096 g, 0.031 mmol) and
[HNMe2Ph][B(C6F5)4] (0.025 g, 0.031 mmol) and cooled to -196
°C. The tube was exposed to CO (5 atm), sealed, and warmed to
-78 °C. The tube was briefly warmed to 23 °C and vigorously
shaken. The tube was kept at -78 °C prior to NMR and IR analysis
Generation of [(p-Tolyldiimine)Pd{C(dO)Me}(CO)][B(C6F5)4]
(7g). This compound was generated quantitatively from 3g,
[Li(Et2O)2.8][B(C6F5)4], and CO (5 atm) using the procedure for
1
at ambient temperature. The H NMR spectrum established that